We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$287B
AUM Growth
-$45.4B
Cap. Flow
+$4.91B
Cap. Flow %
1.71%
Top 10 Hldgs %
16.91%
Holding
3,742
New
162
Increased
2,018
Reduced
1,243
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.98%
2 Healthcare 13.1%
3 Financials 12.8%
4 Consumer Discretionary 9.34%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIO icon
3626
Rio Tinto
RIO
$150B
-10,050
Closed -$808K
RPID icon
3627
Rapid Micro Biosystems
RPID
$99.6M
-35,478
Closed -$241K
RVP icon
3628
Retractable Technologies
RVP
$20.1M
-40,639
Closed -$194K
SAP icon
3629
SAP
SAP
$213B
-2,904
Closed -$322K
SERA icon
3630
Sera Prognostics
SERA
$80.7M
-17,744
Closed -$68K
SLDB icon
3631
Solid Biosciences
SLDB
$786M
-8,427
Closed -$152K
SMMT icon
3632
Summit Therapeutics
SMMT
$9.9B
-61,313
Closed -$151K
FTH
3633
Faeth Therapeutics
FTH
$754M
-2,193
Closed -$102K
SONY icon
3634
Sony
SONY
$136B
-15,880
Closed -$326K
SPRO icon
3635
Spero Therapeutics
SPRO
$68.3M
-65,547
Closed -$571K
SYRE icon
3636
Spyre Therapeutics
SYRE
$8.36B
-4,272
Closed -$246K
TBLL icon
3637
Invesco Short Term Treasury ETF
TBLL
$2.61B
-26,423
Closed -$2.79M
TERN
3638
DELISTED
Terns Pharmaceuticals
TERN
-28,746
Closed -$86K
TGLS icon
3639
Tecnoglass
TGLS
$2.01B
-9,485
Closed -$240K
TNXP icon
3640
Tonix Pharmaceuticals
TNXP
$157M
-2
Closed -$288K
TSAT icon
3641
Telesat
TSAT
$526M
-15,910
Closed -$263K
TSM icon
3642
TSMC
TSM
$1.97T
-2,473
Closed -$258K
TXMD icon
3643
TherapeuticsMD
TXMD
$23.6M
-17,165
Closed -$327K
URGN icon
3644
UroGen Pharma
URGN
$1.96B
-42,689
Closed -$372K
TONX
3645
TON Strategy Co
TONX
$170M
-2
Closed -$19K
VIGL
3646
DELISTED
Vigil Neuroscience
VIGL
-19,198
Closed -$135K
VMD icon
3647
Viemed Healthcare
VMD
$452M
-78,035
Closed -$389K
VRCA icon
3648
Verrica Pharmaceuticals
VRCA
$90.4M
-3,345
Closed -$272K
VTEB icon
3649
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
-7,796
Closed -$402K
VTWO icon
3650
Vanguard Russell 2000 ETF
VTWO
$17.3B
-2,643
Closed -$219K

Similar funds

Charles Schwab's Q2 2022 Portfolio in Review

As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
  • Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
  • Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
  • Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
  • Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
  • Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
  • Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.